These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31826004)

  • 21. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
    Meichner K; Fogle JE; English L; Suter SE
    J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.
    Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    J Vet Intern Med; 2011; 25(2):285-91. PubMed ID: 21314729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma.
    Wilson KS; Sehn LH; Berry B; Chhanabhai M; Fitzgerald CA; Gill KK; Klasa R; Skinnider B; Sutherland J; Connors JM; Gascoyne RD
    Leuk Lymphoma; 2007 Jun; 48(6):1102-9. PubMed ID: 17577773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma.
    Rebhun RB; Lana SE; Ehrhart EJ; Charles JB; Thamm DH
    J Vet Intern Med; 2008; 22(4):989-95. PubMed ID: 18647159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of neutrophilia as a prognostic factor in dogs with multicentric lymphoma treated with a cyclophosphamide, doxorubicin, vincristine, and prednisone-based chemotherapy protocol.
    Veluvolu S; Pellin M; Vos N
    J Am Vet Med Assoc; 2021 Sep; 259(5):494-502. PubMed ID: 34388019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of factors affecting clinical outcome following CHOP-based chemotherapy in dogs with primary nodal diffuse large B-cell lymphoma.
    Childress MO; Ramos-Vara JA; Ruple A
    Vet Comp Oncol; 2018 Mar; 16(1):E159-E168. PubMed ID: 29152834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
    Brown PM; Tzannes S; Nguyen S; White J; Langova V
    Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
    Roider T; Wang X; Hüttl K; Müller-Tidow C; Klapper W; Rosenwald A; Stewart JP; de Castro DG; Dreger P; Hermine O; Kluin-Nelemans HC; Grabe N; Dreyling M; Pott C; Ott G; Hoster E; Dietrich S
    Int J Cancer; 2021 Jan; 148(1):150-160. PubMed ID: 32638373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphoma.
    Marquardt TM; Lindley SES; Smith AN; Cannon CM; Rodriguez CO; Thamm DH; Childress MO; Northrup NC
    J Am Vet Med Assoc; 2019 Jan; 254(2):236-242. PubMed ID: 30605381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of DNA topoisomerase IIa expression in canine lymphomas and its potential role as a marker of sensitivity to anthracycline-based chemotherapy in dogs.
    Klimiuk P; Lopuszynski W; Bulak K; Smiech A; Brzana A
    Folia Histochem Cytobiol; 2020; 58(1):46-53. PubMed ID: 32176312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
    Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A
    Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B-cell lymphoma treated with CHOP chemotherapy.
    Sheng R; Clarke D; Laver T; Meichner K; Northrup N; Tarigo J
    Vet Comp Oncol; 2023 Mar; 21(1):28-35. PubMed ID: 36111442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
    Li J; Fu R; Yang L; Tu W
    Int J Clin Exp Pathol; 2015; 8(11):15019-24. PubMed ID: 26823838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
    Yang JM; Jang JY; Jeon YK; Paik JH
    J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress in dogs with multicentric lymphoma: Effect of chemotherapy on oxidative and antioxidant biomarkers.
    Bottari NB; Munhoz TD; Torbitz VD; Tonin AA; Anai LA; Semolin LM; Jark PC; Bollick YS; Moresco RN; França RT; Lopes ST; Stefani LM; Tinucci-Costa M; Da Silva AS
    Redox Rep; 2015; 20(6):267-74. PubMed ID: 26274787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
    Goodman IH; Moore AS; Frimberger AE
    Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in minimal residual disease in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy.
    Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    J Vet Intern Med; 2011; 25(2):292-6. PubMed ID: 21314721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour-specific microRNA expression pattern in canine intestinal T-cell-lymphomas.
    Joos D; Leipig-Rudolph M; Weber K
    Vet Comp Oncol; 2020 Dec; 18(4):502-508. PubMed ID: 31997569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.